Practical Key Points for Quality Control and Cold Chain Management of Biological Reagents

The foundational position of biological reagents in life sciences and industrial applications

Biological reagents encompass categories such as nucleic acid extraction and purification reagents, PCR and real-time fluorescent quantitative PCR-related reagents, antibodies and antigens for immunoassays, cell culture supplements, enzymes, and substrates. They serve as important support for basic life science research, in vitro diagnostic reagent development, and biopharmaceutical quality control. Whether it is gene function research in university laboratories or process development in in vitro diagnostic companies, it is necessary to select appropriate biological reagents according to experimental objectives and to pay attention to their purity, activity, lot-to-lot stability, and applicable sample types. Currently, there is a wide variety of biological reagents on the market, and products from different suppliers differ in formulation, dosage form, and packaging format. Before procurement, users should conduct a thorough evaluation in combination with their own platforms and validation protocols, and should not rely solely on promotional materials as the only basis for judgment.

Common steps and evaluation dimensions in quality control

Quality control of biological reagents can generally be carried out through steps such as raw material screening, preparation processes, aliquoting environment, and finished product testing. In terms of raw materials, the source and purity of core components such as recombinant proteins, antibodies, and enzymes directly affect reagent performance, and manufacturers usually establish supplier audit and incoming inspection procedures. During preparation and aliquoting, factors such as cleanliness level, temperature, pH value, and ionic strength need to be maintained within set ranges to avoid microbial contamination or reduced activity. Finished product testing generally includes items such as appearance, fill volume, concentration or activity, sterility or microbial limits, and functional testing, with specific indicators varying by reagent category. For users, the Certificate of Analysis (COA) of a product can be used to understand lot information, but the COA itself cannot replace performance validation under one's own experimental system. It is recommended that laboratories set up parallel controls or reference materials when introducing a certain type of biological reagent for the first time, in order to determine its suitability in the target experiment.

Key points of storage, transportation, and cold chain management

Many biological reagents are temperature-sensitive. Common storage conditions include room temperature, 2~8°C, -20°C, and -80°C, and the specific conditions should be based on those indicated on the product label and instructions. During cold chain transportation, attention should be paid to whether temperature recorders or temperature indicator devices are intact, and whether the outer packaging shows damage or leakage. After receiving the reagents, the product name, specifications, lot number, and expiration date should be checked as soon as possible, and they should be stored according to the indicated conditions. Repeated freeze-thaw cycles may affect the activity of some enzymes, antibodies, or standards. Therefore, for reagents requiring low-temperature storage, it is recommended to aliquot them according to expected usage to reduce the number of repeated freeze-thaw cycles. Laboratories should also establish inspection and alarm mechanisms for temperature-controlled equipment and regularly check the temperature stability of refrigerators and cold storage rooms to prevent reagent failure caused by equipment malfunction. It should be noted that different reagents have different degrees of tolerance to temperature fluctuations and cannot be judged simply by generalizing based on "refrigerated" or "frozen." The instructions should be read before first use and storage requirements should be recorded.

General requirements for compliance, labeling, and instructions

In the mainland China market, for biological reagents used for in vitro diagnostics or scientific research purposes, their labels and instructions usually need to comply with relevant regulations and standards regarding product name, composition, intended use, storage conditions, expiration date, warning information, and other requirements. Manufacturing or sales companies should ensure that descriptions are objective and do not contain content that exaggerates functions or promises efficacy. For biological reagents intended for research use only (RUO), they should be clearly labeled with "For Research Use Only" or similar prompts to avoid confusion with clinical diagnostic uses. When tendering or comparing prices, procurement personnel may require suppliers to provide quality system documents, summaries of stability data, and after-sales service descriptions, but should not replace validation of actual performance with a single promotional statement. A common industry practice is to combine one's own quality management system to carry out supplier audits and change management for key biological reagents, ensuring continuity of supply.

Practical recommendations for selection and use

During the selection stage, it is recommended to compare from the following dimensions:

Compatibility of the reagent's applicable sample types with downstream experiments;

Whether the minimum packaging specification matches routine usage, avoiding activity risks caused by long-term inventory;

Whether the supplier can provide stable lot-to-lot consistency and necessary technical support;

Whether transportation and storage conditions match the laboratory's existing hardware conditions;

Whether product-related materials are complete, such as instructions, Safety Data Sheets (SDS), and quality documents.

In actual use, operating procedures should be strictly followed to avoid cross-contamination between different reagents, and records should be kept of opening dates, usage amounts, and remaining amounts. For key experiments, it is recommended to set up positive controls, negative controls, and internal references to help determine whether reagent performance is within an acceptable range.In summary, the selection and management of biological reagents is not a simple procurement activity, but rather a systematic effort involving quality, storage, compliance, and performance verification. Only by establishing clear processes at each stage can the reproducibility of experimental results be improved and data deviations caused by reagent variability be reduced.